Funder
Council of Science & Technology,Uttar Pradesh
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2021 Report). 2020 Global Initiative for Chronic Obstructive Lung Disease, Inc. https://goldcopd.org/2021-gold-reports/ (assessed on 15 December 2020).
2. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology. 2008;13(7):1014–21.
3. Uysal P, Uzun H. Relationship between circulating serpina3g, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and-2 with chronic obstructive pulmonary disease severity. Biomolecules. 2019;9(2):62.
4. Churg A, Zhou S, Wright JL. Matrix metalloproteinases in COPD. Eur Respir J. 2012;39:197–209.
5. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious and multifaceted. Physiol Rev. 2007;87(1):69–98.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献